John C. Su

发表

Drug‐induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis

L. J. Dang, J. Lubel, S. Gunatheesan, 2014, The Australasian journal of dermatology.

Artificial Intelligence in Dermatology—Where We Are and the Way to the Future: A Review

Daniel T Hogarty, M. Hossny, S. Nahavandi, 2019, American Journal of Clinical Dermatology.

A randomized, controlled trial of oral propranolol in infantile hemangioma.

C. Berul, S. Heritier, S. Barbarot, 2015, The New England journal of medicine.

Debunking the Myth of Wool Allergy: Reviewing the Evidence for Immune and Non-immune Cutaneous Reactions.

M. Tang, C. Katelaris, John C. Su, 2017, Acta dermato-venereologica.

A case of PHACE syndrome

M. Marks, John C. Su, P. Bekhor, 2005, The Australasian journal of dermatology.

CARD14‐associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris

A. Bowcock, K. Holland, R. Lifton, 2018, Journal of the American Academy of Dermatology.

Prevention of atopic dermatitis: Etiological considerations and identification of potential strategies

A. Lowe, John C. Su, 2019, Indian Journal of Paediatric Dermatology.

Age at onset and persistence of eczema are related to subsequent risk of asthma and hay fever from birth to 18 years of age

A. Lowe, L. Gurrin, M. Abramson, 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Skin of Aboriginal Children

John C. Su, C. Heyes, 2015 .

Management of atopic dermatitis: a narrative review

John C. Su, M. Goh, Jenny S W Yun, 2022, The Medical journal of Australia.

Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care

John C. Su, A. Chong, M. Howard, 2018, American Journal of Clinical Dermatology.

The skin as a target for prevention of the atopic march.

A. Lowe, M. Tang, D. Leung, 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council

C. Flohr, J. Silverberg, T. Bieber, 2017, Journal of the American Academy of Dermatology.

Establishing subclasses of childhood eczema, their risk factors and prognosis

A. Lowe, M. Abramson, J. Perret, 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Retrospective review of screening for Sturge‐Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high‐risk port‐wine stains

M. Mackay, M. Ditchfield, John C. Su, 2018, Pediatric dermatology.

Screening for Sturge‐Weber syndrome: A state‐of‐the‐art review

M. Mackay, M. Ditchfield, John C. Su, 2018, Pediatric dermatology.

Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement

G. Fischer, John C. Su, A. Halbert, 2015, The Australasian journal of dermatology.

Drug induced vitiligo‐like depigmentation from a CDK 4/6 inhibitor

A. Chan, John C. Su, A. Yazdabadi, 2021, Asia-Pacific journal of clinical oncology.

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

J. Werth, J. Schlessinger, L. Takiya, 2020, American Journal of Clinical Dermatology.

Atopic eczema: its impact on the family and financial cost

G. Varigos, A. Kemp, John C. Su, 1997, Archives of disease in childhood.

Successful re‐introduction of vitamin B12 after using isotretinoin to treat severe acne medicamentosa

John C. Su, R. Nguyen, Helena Lolatgis, 2016, The Australasian journal of dermatology.

Trigeminal trophic syndrome

John C. Su, N. Downes, 1997, The Australasian journal of dermatology.

Consensus statement for the treatment of infantile haemangiomas with propranolol

A. Robinson, G. Fischer, D. Murrell, 2017, The Australasian journal of dermatology.

Common rashes in neonates.

John C. Su, 2012, Australian family physician.

Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.

B. Chung, R. Hennekam, L. Biesecker, 2016, American journal of human genetics.

Sweet’s Syndrome with Postinflammatory Elastolysis and Takayasu Arteritis in a Child: A Case Report and Literature Review

John C. Su, D. Macgregor, J. Akikusa, 2012, Pediatric dermatology.

Association Between Discoid Lupus Erythematosus and Chronic Granulomatous Disease—Report of Two Cases and Review of the Literature

John C. Su, C. Mclean, T. Cole, 2016, Pediatric dermatology.

Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa.

G. Varigos, D. Murrell, John C. Su, 2010, Archives of dermatology.

Treatment of acne vulgaris

John C. Su, R. Nguyen, 2011 .

Association between ambient air pollution and development and persistence of atopic and non‐atopic eczema in a cohort of adults

L. Knibbs, A. Lowe, M. Abramson, 2021, Allergy.

Fatal granulomatous amoebic encephalitis caused by Balamuthia mandrillaris

C. Cooke‐Yarborough, A. Kemp, John C. Su, 1997, The Medical journal of Australia.

Multiple clustered dermatofibroma presenting in a segmental distribution

John C. Su, D. Orchard, J. Magee, 2016, The Australasian journal of dermatology.

Blue–black discolouration of the proximal lunula of the thumbnail

John C. Su, J. Kern, Chin-Guan Tan, 2019, The Australasian journal of dermatology.

Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).

D. Murrell, John C. Su, B. Daniel, 2014, Journal of the American Academy of Dermatology.

A Review of 52 Pedigrees with Epidermolysis Bullosa Simplex Identifying Ten Novel Mutations in KRT5 and KRT14 in Australia.

D. Murrell, John C. Su, A. Harris, 2017, Acta dermato-venereologica.

A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)

D. Murrell, John C. Su, J. Kern, 2021, JAAD international.

Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Diverse Skin Types in Australia

A. Lowe, John C. Su, Zack Holmes, 2023, Journal of clinical medicine.

Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis

A. Paller, J. Thyssen, K. Yamamoto‐Hanada, 2023, JAMA dermatology.

PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy

J. Hui, A. Lowe, G. Varigos, 2019, BMJ Open.

Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults

Paul D. Thomas, L. Knibbs, A. Lowe, 2020 .

Interim Efficacy and Safety Results from the Phase 2 NURTURE Study Evaluating Nusinersen in Presymptomatic Infants with Spinal Muscular Atrophy (S46.003)

E. Bertini, W. Hwu, D. Vivo, 2017 .

Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts

C. Bodemer, J. Uitto, E. Sprecher, 2020, Journal of the American Academy of Dermatology.

Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagen

H. Shimizu, G. Varigos, D. Murrell, 2011, The Australasian journal of dermatology.

A phase i study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates

A. Lowe, L. Gurrin, G. Varigos, 2012, BMC Dermatology.

Determining Effects of Superfine Sheep wool in INfantile Eczema (DESSINE): a randomized paediatric crossover study.

A. Lowe, S. Donath, John C. Su, 2017 .